Supplementary Tables 1-2, Figures 1-4 from VEGF Receptor Inhibitors Block the Ability of Metronomically Dosed Cyclophosphamide to Activate Innate Immunity–Induced Tumor Regression
Authors:
- Joshua C. DoloffJDJoshua C. Doloff
- David J. WaxmanDWDavid J. Waxman
Open Access
- 30 March 2023
- other
- Published by American Association for Cancer Research (AACR)